Literature DB >> 22941872

Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.

Simona Baldi1, Maurizio Innocenti, Silvia Frascerra, Monica Nannipieri, Alberto Lippi, Paolo Rindi, Ele Ferrannini.   

Abstract

BACKGROUND: Cardiovascular diseases represent the major cause of mortality in hemodialysis (HD) patients. HD increases oxidative stress and oxidation of low-density lipoprotein (LDL) is a crucial step in the development of atherosclerosis. Vitamin E has been shown to reduce LDL oxidation. Our aim was to test the effect of a single HD session and chronic vitamin E supplementation on LDL oxidizability in HD patients.
METHODS: LDL susceptibility to copper-induced oxidation (lag-phase, LP) was measured in 19 HD patients, both immediately before and after hemodialysis; 18 age-matched healthy subjects served as controls. Both pre-HD and post-HD measurements were repeated after 12 weeks of vitamin E supplementation (800 IU/day) in a placebo-controlled, randomized design.
RESULTS: At baseline, HD patients showed hypertriglyceridemia, a significant triglyceride enrichment in LDL and HDL and an enhanced LDL resistance to oxidation (186 ± 6 vs. 163 ± 4 min, p<0.003). A single HD session decreased (to 172 ± 6 min, or -8%, p<0.002), and chronic vitamin E administration increased, LDL resistance to oxidation (+19%, p = 0.002 vs. placebo) without changing the serum lipid profile or lipoprotein lipid composition.
CONCLUSIONS: We conclude that in patients on chronic hemodialysis, hypertriglyceridemia and triglyceride enrichment of LDL and HDL particles are associated with increased resistance of LDL to in vitro oxidation despite the fact that each dialysis session acutely increases LDL oxidizability. Vitamin E supplementation improves LDL resistance to oxidation without modifying circulating lipid levels and partitioning.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941872     DOI: 10.5301/jn.5000190

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

1.  Vitamin E conditionally inhibits atherosclerosis in ApoE knockout mice by anti-oxidation and regulation of vasculature gene expressions.

Authors:  Futian Tang; Meili Lu; Suping Zhang; Meng Mei; Tieqiao Wang; Peiqing Liu; Hongxin Wang
Journal:  Lipids       Date:  2014-11-11       Impact factor: 1.880

2.  Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet.

Authors:  Mohsen Meydani; Paul Kwan; Michael Band; Ashley Knight; Weimin Guo; Jason Goutis; Jose Ordovas
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

Review 3.  The Effect of Polyphenol-Rich Interventions on Cardiovascular Risk Factors in Haemodialysis: A Systematic Review and Meta-Analysis.

Authors:  Wolfgang Marx; Jaimon Kelly; Skye Marshall; Stacey Nakos; Katrina Campbell; Catherine Itsiopoulos
Journal:  Nutrients       Date:  2017-12-11       Impact factor: 5.717

Review 4.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

Review 5.  A Systematic Review of Effects of Vitamin E on the Cardiovascular System.

Authors:  Sunil Shah; Yasir Shiekh; Jannel A Lawrence; Francis Ezekwueme; Mohammad Alam; Saru Kunwar; Domonick K Gordon
Journal:  Cureus       Date:  2021-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.